transwell inserts corning costar 3422 Search Results


8-μm pore size transwell filter insert costar 3422  (Corning Life Sciences)
90
Corning Life Sciences 8-μm pore size transwell filter insert costar 3422
Doxorubicin inhibits proliferation, migration and invasion of meningioma. ( A ) Correlation of compound with differently expressed mRNA: Heatmap showing compounds (top) from the CMap shares mechanisms of action and the mechanisms of action was sorted by descending number of compounds (right); “ComplexHeatmap” R package (version 3.15) was used to graph the result. ( B ) The molecular structure of Doxorubicin; ( C ) The dose-curve of Doxorubicin in IOMM-Lee cell line; ( D ) CCK-8 assay of the cell proliferation ability in IOMM-Lee cells upon Doxorubicin or DMSO treatment; ( E ) EdU assay of the cell proliferation ability in IOMM-Lee cells upon Doxorubicin or DMSO treatment. Scale bar: 125 μm; ( F ) Statistical analysis of the EdU-positive cell ratio; ( G ) Wound healing assay showed delayed closure of the wound gap upon Doxorubicin treatment. ( H ) Statistical analysis of the cell migration in the scratch wound healing assays. ( I ) <t>Transwell</t> invasion and migration assay of IOMM-Lee cells upon Doxorubicin or DMSO treatment. ( J ) Statistical analysis of the cell numbers passing through the transwell chamber. All data were the means ± SD. Results triplicate and repeated at least three times. Results are expressed as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
8 μm Pore Size Transwell Filter Insert Costar 3422, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transwell+inserts+corning+costar+3422/8+%CE%BCm+pore+size+transwell+filter+insert+costar+3422/pmc10079659-123-12-19
Average 90 stars, based on 1 article reviews
8-μm pore size transwell filter insert costar 3422 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
transwell cell culture inserts with an 8-μm pore costar 3422  (Corning Life Sciences)
90
Corning Life Sciences transwell cell culture inserts with an 8-μm pore costar 3422
Doxorubicin inhibits proliferation, migration and invasion of meningioma. ( A ) Correlation of compound with differently expressed mRNA: Heatmap showing compounds (top) from the CMap shares mechanisms of action and the mechanisms of action was sorted by descending number of compounds (right); “ComplexHeatmap” R package (version 3.15) was used to graph the result. ( B ) The molecular structure of Doxorubicin; ( C ) The dose-curve of Doxorubicin in IOMM-Lee cell line; ( D ) CCK-8 assay of the cell proliferation ability in IOMM-Lee cells upon Doxorubicin or DMSO treatment; ( E ) EdU assay of the cell proliferation ability in IOMM-Lee cells upon Doxorubicin or DMSO treatment. Scale bar: 125 μm; ( F ) Statistical analysis of the EdU-positive cell ratio; ( G ) Wound healing assay showed delayed closure of the wound gap upon Doxorubicin treatment. ( H ) Statistical analysis of the cell migration in the scratch wound healing assays. ( I ) <t>Transwell</t> invasion and migration assay of IOMM-Lee cells upon Doxorubicin or DMSO treatment. ( J ) Statistical analysis of the cell numbers passing through the transwell chamber. All data were the means ± SD. Results triplicate and repeated at least three times. Results are expressed as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
Transwell Cell Culture Inserts With An 8 μm Pore Costar 3422, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transwell+inserts+corning+costar+3422/transwell+cell+culture+inserts+with+an+8+%CE%BCm+pore+costar+3422/pm38320455-123-7-17
Average 90 stars, based on 1 article reviews
transwell cell culture inserts with an 8-μm pore costar 3422 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Doxorubicin inhibits proliferation, migration and invasion of meningioma. ( A ) Correlation of compound with differently expressed mRNA: Heatmap showing compounds (top) from the CMap shares mechanisms of action and the mechanisms of action was sorted by descending number of compounds (right); “ComplexHeatmap” R package (version 3.15) was used to graph the result. ( B ) The molecular structure of Doxorubicin; ( C ) The dose-curve of Doxorubicin in IOMM-Lee cell line; ( D ) CCK-8 assay of the cell proliferation ability in IOMM-Lee cells upon Doxorubicin or DMSO treatment; ( E ) EdU assay of the cell proliferation ability in IOMM-Lee cells upon Doxorubicin or DMSO treatment. Scale bar: 125 μm; ( F ) Statistical analysis of the EdU-positive cell ratio; ( G ) Wound healing assay showed delayed closure of the wound gap upon Doxorubicin treatment. ( H ) Statistical analysis of the cell migration in the scratch wound healing assays. ( I ) Transwell invasion and migration assay of IOMM-Lee cells upon Doxorubicin or DMSO treatment. ( J ) Statistical analysis of the cell numbers passing through the transwell chamber. All data were the means ± SD. Results triplicate and repeated at least three times. Results are expressed as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.

Journal: Scientific Reports

Article Title: Prognostic factors and Doxorubicin involved in malignant progression of meningioma

doi: 10.1038/s41598-023-28996-0

Figure Lengend Snippet: Doxorubicin inhibits proliferation, migration and invasion of meningioma. ( A ) Correlation of compound with differently expressed mRNA: Heatmap showing compounds (top) from the CMap shares mechanisms of action and the mechanisms of action was sorted by descending number of compounds (right); “ComplexHeatmap” R package (version 3.15) was used to graph the result. ( B ) The molecular structure of Doxorubicin; ( C ) The dose-curve of Doxorubicin in IOMM-Lee cell line; ( D ) CCK-8 assay of the cell proliferation ability in IOMM-Lee cells upon Doxorubicin or DMSO treatment; ( E ) EdU assay of the cell proliferation ability in IOMM-Lee cells upon Doxorubicin or DMSO treatment. Scale bar: 125 μm; ( F ) Statistical analysis of the EdU-positive cell ratio; ( G ) Wound healing assay showed delayed closure of the wound gap upon Doxorubicin treatment. ( H ) Statistical analysis of the cell migration in the scratch wound healing assays. ( I ) Transwell invasion and migration assay of IOMM-Lee cells upon Doxorubicin or DMSO treatment. ( J ) Statistical analysis of the cell numbers passing through the transwell chamber. All data were the means ± SD. Results triplicate and repeated at least three times. Results are expressed as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.

Article Snippet: Migration or invasion assays were performed using 24-well plates inserted by 8-μm pore size transwell filter insert (Costar 3422 [Corning, Corning, New York, USA]) with or without pre-coated diluted Matrigel (1:8) (Becton Dickinson and Co., Franklin Lakes, NJ, USA).

Techniques: Migration, CCK-8 Assay, EdU Assay, Wound Healing Assay